Kewaunee Scientific to Report Results for Second Quarter Fiscal Year 2026
Financial Results Announcement: Kewaunee Scientific Corporation plans to release its second quarter fiscal year 2026 financial results on December 10, 2025, after trading hours, with details available on their website.
Company Overview: Founded in 1906, Kewaunee Scientific is a global leader in laboratory and healthcare furniture, with manufacturing facilities in the U.S. and India, and sales offices in multiple countries.
Acquisition of Nu Aire: Kewaunee has acquired Nu Aire, a manufacturer of laboratory products, enhancing its portfolio with items like biological safety cabinets and CO2 incubators.
Forward-Looking Statements: The press release includes forward-looking statements that are subject to various risks and uncertainties, which could significantly impact the company's future performance and results.
Trade with 70% Backtested Accuracy
Analyst Views on KEQU
About KEQU
About the author

- Exhibition Opportunity: Kewaunee Scientific Corporation will attend the analytica tradeshow in Munich from March 24-27, 2026, showcasing its laboratory infrastructure and safety solutions alongside its recently acquired subsidiary, Nu Aire, and is expected to attract over 30,000 professionals, enhancing brand visibility and market influence.
- Product Portfolio Showcase: The event will feature a comprehensive product lineup from Kewaunee and Nu Aire, including biological safety cabinets and CO2 incubators, aimed at addressing modern laboratory needs for safety and efficiency, thereby enhancing customer trust and driving sales growth.
- Industry Partnerships: Kewaunee will collaborate with its European market partner, ibs tecnomara, to demonstrate how coordinated infrastructure and containment solutions can enhance laboratory performance, further solidifying its leadership position in the industry.
- Strategic Commitment: Kewaunee's CEO, Thomas D. Hull III, emphasized that the tradeshow represents a vital opportunity to connect with global laboratory users and partners, showcasing the company's commitment to supporting laboratory projects throughout their lifecycle, indicating potential for future business growth.
- Earnings Release Schedule: Kewaunee Scientific Corporation plans to announce its third quarter fiscal year 2026 financial results on March 11, 2026, after market close, which is expected to provide investors with insights into the company's financial health and operational performance.
- Company Overview: Founded in 1906, Kewaunee is a global leader in the design, manufacture, and installation of laboratory, healthcare, and technical furniture products, including steel and wood casework and fume hoods, serving both domestic and international markets.
- Acquisition Details: The recent acquisition of Nu Aire, a manufacturer of biological safety cabinets and ultra-low freezers, enhances Kewaunee's product portfolio, thereby strengthening its competitive position in the laboratory equipment market.
- Global Business Presence: Kewaunee operates sales offices in the U.S., India, Saudi Arabia, and Singapore, with manufacturing facilities in Statesville and Bangalore, reflecting its strategic focus on global market expansion and production capabilities.
- Stock Performance: Agnico Eagle's shares have surged 63.4% over the past six months, outperforming the Zacks Mining - Gold industry, which gained 85.9%, indicating its relative strength in the market.
- Earnings Estimates Rising: The company's earnings estimates for Q4 2025 have been increasing over the past month, reflecting growing market confidence in its future growth potential, particularly with cost savings expected from the Kittila expansion project.
- Strengthened Market Position: The merger with Kirkland Lake Gold has established Agnico Eagle as the industry's highest-quality senior gold producer, with a robust pipeline of development and exploration projects ensuring sustainable growth.
- Diversification Strategy: By maintaining prudent debt management and financial flexibility, the company mitigates risks, with higher gold prices expected to further enhance its margins, thereby boosting investor confidence.

- Earnings Outlook Improvement: Agnico Eagle Mines has seen its stock rise 63.4% over the past six months, outperforming the Zacks Mining - Gold industry’s 85.9% gain, reflecting market optimism regarding its Q4 earnings estimates.
- Project Expansion and Acquisitions: The company is enhancing its market position through the Kittila expansion project and acquisitions like Hope Bay, along with the merger with Kirkland Lake Gold, which are expected to drive future production growth and cost savings.
- Enhanced Financial Flexibility: Agnico Eagle mitigates risks through prudent debt management and strategic diversification, while higher gold prices are anticipated to boost the company's margins, further strengthening its financial stability.
- Sustainable Growth Pipeline: The merged entity now possesses an extensive pipeline of development and exploration projects, ensuring potential for sustainable growth that aligns with industry demand for high-quality gold producers.
- Significant Sales Growth: Kewaunee reported sales of $70.1 million for Q2 FY2026, reflecting a 46.8% increase from $47.8 million in the same quarter last year, indicating strong market demand and operational performance.
- Strong Domestic Performance: Domestic sales reached $55.2 million, up 51.7% year-over-year, demonstrating resilience despite lower manufacturing volumes in laboratory construction, with Nu Aire's strong performance offsetting some of the challenges, highlighting the success of the company's diversification strategy.
- Continued International Growth: International sales amounted to $14.9 million, a 31.0% increase from $11.4 million in the prior year, primarily driven by the delivery of large projects booked in previous periods, showcasing the company's expansion potential in global markets.
- Improved Financial Position: As of October 31, 2025, the company had cash on hand of $13.7 million, down from $17.2 million on April 30, but working capital increased to $67.8 million, indicating financial stability amid ongoing investments and growth initiatives.
Profit Decline: Kewaunee Scientific Corporation reported a profit of $2.538 million for the second quarter, down from $4.204 million the previous year.
Earnings Per Share: The earnings per share (EPS) decreased to $0.82 from $1.41 year-over-year.
Revenue Growth: The company's revenue increased by 46.8% to $70.096 million, compared to $47.764 million last year.
Earnings Overview: Key figures include earnings of $2.538 million, EPS of $0.82, and revenue of $70.096 million for the current quarter.








